Interpace Diagnostics Group Company Profile (NASDAQ:IDXG)

About Interpace Diagnostics Group (NASDAQ:IDXG)

Interpace Diagnostics Group logoInterpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Business Support Services
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:IDXG
  • CUSIP: 69329V10
  • Web: www.interpacediagnostics.com
Capitalization:
  • Market Cap: $36.35 million
  • Outstanding Shares: 22,164,000
Average Prices:
  • 50 Day Moving Avg: $1.25
  • 200 Day Moving Avg: $1.72
  • 52 Week Range: $0.70 - $19.80
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $13.76 million
  • Price / Sales: 2.56
  • Book Value: $1.81 per share
  • Price / Book: 0.88
Profitability:
  • EBIDTA: ($10,890,000.00)
  • Net Margins: -37.08%
  • Return on Equity: -32.06%
  • Return on Assets: -11.22%
Debt:
  • Current Ratio: 1.69%
  • Quick Ratio: 1.69%
Misc:
  • Average Volume: 3.46 million shs.
  • Beta: 1.72
  • Short Ratio: 1.08
 

Frequently Asked Questions for Interpace Diagnostics Group (NASDAQ:IDXG)

What is Interpace Diagnostics Group's stock symbol?

Interpace Diagnostics Group trades on the NASDAQ under the ticker symbol "IDXG."

How were Interpace Diagnostics Group's earnings last quarter?

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) released its earnings results on Thursday, August, 10th. The company reported ($0.65) EPS for the quarter. The business had revenue of $3.86 million for the quarter. Interpace Diagnostics Group had a negative return on equity of 32.06% and a negative net margin of 37.08%. View Interpace Diagnostics Group's Earnings History.

Where is Interpace Diagnostics Group's stock going? Where will Interpace Diagnostics Group's stock price be in 2017?

1 analysts have issued 12 month price targets for Interpace Diagnostics Group's shares. Their predictions range from $5.00 to $5.00. On average, they expect Interpace Diagnostics Group's stock price to reach $5.00 in the next year. View Analyst Ratings for Interpace Diagnostics Group.

Are investors shorting Interpace Diagnostics Group?

Interpace Diagnostics Group saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 3,949,802 shares, an increase of 44.5% from the August 15th total of 2,732,938 shares. Based on an average daily trading volume, of 5,999,808 shares, the short-interest ratio is currently 0.7 days. Currently, 17.9% of the company's stock are short sold.

Who are some of Interpace Diagnostics Group's key competitors?

Who are Interpace Diagnostics Group's key executives?

Interpace Diagnostics Group's management team includes the folowing people:

  • Stephen J. Sullivan, Chairman of the Board
  • Jack E. Stover CPA, President, Chief Executive Officer, Director
  • James Early, Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
  • Joseph D. Keegan Ph.D., Independent Director

Who owns Interpace Diagnostics Group stock?

Interpace Diagnostics Group's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Susquehanna International Group LLP (3.84%). View Institutional Ownership Trends for Interpace Diagnostics Group.

Who bought Interpace Diagnostics Group stock? Who is buying Interpace Diagnostics Group stock?

Interpace Diagnostics Group's stock was acquired by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP. View Insider Buying and Selling for Interpace Diagnostics Group.

How do I buy Interpace Diagnostics Group stock?

Shares of Interpace Diagnostics Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Interpace Diagnostics Group's stock price today?

One share of Interpace Diagnostics Group stock can currently be purchased for approximately $1.59.


MarketBeat Community Rating for Interpace Diagnostics Group (NASDAQ IDXG)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  103
MarketBeat's community ratings are surveys of what our community members think about Interpace Diagnostics Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Interpace Diagnostics Group (NASDAQ:IDXG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (214.47% upside)

Analysts' Ratings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/15/2017Maxim GroupInitiated CoverageBuy -> Buy$5.00HighView Rating Details
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Earnings History by Quarter for Interpace Diagnostics Group (NASDAQ IDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($0.65)$3.86 millionViewN/AView Earnings Details
5/15/2017Q1 2017$0.42$3.47 millionViewN/AView Earnings Details
11/12/2015Q3($0.40)($0.31)$32.35 million$36.60 millionViewListenView Earnings Details
8/13/2015Q215($0.46)($0.44)$32.62 million$34.10 millionViewListenView Earnings Details
5/12/2015Q115($0.48)($0.25)$33.20 million$38.30 millionViewListenView Earnings Details
3/3/2015Q414($0.50)($0.27)$140.87 million$28.90 millionViewListenView Earnings Details
11/3/2014Q3($0.19)($0.29)$33.40 million$29.20 millionViewListenView Earnings Details
8/13/2014Q2($0.12)($0.17)$35.60 million$31.60 millionViewListenView Earnings Details
5/7/2014Q1($0.11)($0.11)$39.48 million$32.80 millionViewListenView Earnings Details
2/27/2014Q4($0.11)($0.25)$38.09 million$36.41 millionViewListenView Earnings Details
11/12/2013Q3($0.23)($0.14)ViewListenView Earnings Details
8/5/2013Q2 2013($0.11)($0.06)$35.26 million$37.20 millionViewListenView Earnings Details
3/6/2013Q4 2012($0.07)($1.64)$36.90 million$35.60 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Interpace Diagnostics Group (NASDAQ:IDXG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Interpace Diagnostics Group (NASDAQ:IDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Ownership Percentage: 0.70%
Institutional Ownership Percentage: 7.41%
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Institutional Ownership by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2014Graham G MiaoCFOBuy22,000$1.65$36,300.00View SEC Filing  
11/10/2014Nancy LurkerCEOBuy49,000$1.75$85,750.00View SEC Filing  
11/7/2014Gerald R Melillo JrInsiderBuy5,000$1.58$7,900.00View SEC Filing  
11/7/2014Jeffrey Edward SmithVPBuy200,000$1.75$350,000.00View SEC Filing  
11/6/2014Nancy LurkerCEOBuy57,000$1.74$99,180.00View SEC Filing  
11/5/2014Gerald P BelleDirectorBuy57,300$1.71$97,983.00View SEC Filing  
11/18/2013Gerald BelleDirectorBuy20,400$5.21$106,284.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Interpace Diagnostics Group (NASDAQ:IDXG)
Latest Headlines for Interpace Diagnostics Group (NASDAQ:IDXG)
Source:
DateHeadline
americanbankingnews.com logoInterpace Diagnostics Group, Inc. (IDXG) Sees Large Increase in Short Interest
www.americanbankingnews.com - September 16 at 2:14 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Appoints Dr. Felice Schnoll-Sussman to Board
www.streetinsider.com - September 14 at 11:44 PM
finance.yahoo.com logoInterpace Diagnostics Announces Appointment of New Director
finance.yahoo.com - September 14 at 6:19 AM
reuters.com logoBRIEF-Interpace Diagnostics Group Inc - ‍ assigned a new, discreet CPT code to facilitate reimbursement of Thyramir
www.reuters.com - September 12 at 1:15 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Reports New CPT Code for Reimbursement of Molecular Thyroid Test
www.streetinsider.com - September 12 at 1:15 AM
americanbankingnews.com logoValuEngine Upgrades Interpace Diagnostics Group, Inc. (IDXG) to "Sell"
www.americanbankingnews.com - September 11 at 10:54 PM
finance.yahoo.com logoInterpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test
finance.yahoo.com - September 11 at 8:13 PM
americanbankingnews.com logo Interpace Diagnostics Group, Inc. (IDXG) Given $5.00 Average Price Target by Analysts
www.americanbankingnews.com - September 10 at 4:10 PM
americanbankingnews.com logoComparing Interpace Diagnostics Group (IDXG) and its Peers
www.americanbankingnews.com - September 9 at 10:24 AM
finance.yahoo.com logoInterpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City
finance.yahoo.com - September 7 at 8:01 PM
finance.yahoo.com logoInterpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price
finance.yahoo.com - August 31 at 7:46 PM
finance.yahoo.com logoInterpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 31 at 7:46 PM
reuters.com logoBRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement
www.reuters.com - August 29 at 5:25 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Announces Renewal and Extension Pact with LabCorp (LH)
www.streetinsider.com - August 29 at 5:25 AM
finance.yahoo.com logoEarnings Review and Free Research Report: Priceline Group’s Adjusted Diluted EPS Increased 20% on a Y-o-Y Basis
finance.yahoo.com - August 28 at 7:21 PM
finance.yahoo.com logoInterpace Diagnostics Announces Renewal and Extension of LabCorp National Agreement
finance.yahoo.com - August 28 at 7:21 PM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 6:06 AM
streetinsider.com logoInterpace Diagnostics (IDXG) Says Its Thyroid Test Will be Covered by Oxford Health Plans
www.streetinsider.com - August 17 at 12:45 AM
finance.yahoo.com logoInterpace Diagnostics Announces Coverage of Thyroid Test by Oxford Health Plans
finance.yahoo.com - August 16 at 7:43 PM
finance.yahoo.com logo3 Stocks You Must Know About Before Wednesday's Opening Bell
finance.yahoo.com - August 16 at 7:43 PM
americanbankingnews.com logoInterpace Diagnostics Group, Inc. (IDXG) Coverage Initiated at Maxim Group
www.americanbankingnews.com - August 15 at 6:40 PM
americanbankingnews.com logoHead-To-Head Contrast: Brady Corporation (BRC) and Interpace Diagnostics Group (IDXG)
www.americanbankingnews.com - August 15 at 2:20 AM
americanbankingnews.com logoAnalyzing Interpace Diagnostics Group (IDXG) and Brink's Company (The) (BCO)
www.americanbankingnews.com - August 13 at 6:08 AM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 11 at 8:12 PM
americanbankingnews.com logoInterpace Diagnostics Group, Inc. (NASDAQ:IDXG) Posts Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 12:17 PM
finance.yahoo.com logoInterpace Diagnostics Group Reports Second Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
finance.yahoo.com - August 11 at 3:28 AM
finance.yahoo.com logoInterpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Thursday August 10, 2017
finance.yahoo.com - August 9 at 7:58 PM
americanbankingnews.com logoZacks: Interpace Diagnostics Group Inc (NASDAQ:IDXG) Given Consensus Recommendation of "" by Analysts
www.americanbankingnews.com - August 2 at 7:18 AM
finance.yahoo.com logoInterpace Diagnostics Launches Product Extension at World Conference on Thyroid Cancer
finance.yahoo.com - August 1 at 3:21 PM
americanbankingnews.com logoShort Interest in Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Increases By 46.2%
www.americanbankingnews.com - July 29 at 7:01 AM
finance.yahoo.com logoInterpace Diagnostics Announces Cigna Coverage of ThyGenX®
finance.yahoo.com - July 27 at 10:15 PM
americanbankingnews.com logoInterpace Diagnostics Group (NASDAQ:IDXG) and Cintas Corporation (CTAS) Head to Head Survey
www.americanbankingnews.com - July 16 at 8:14 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Enters National Contract with Aetna for ThyGenX and ThyraMIR Tests
www.streetinsider.com - June 28 at 7:21 PM
finance.yahoo.com logoInterpace Diagnostics Announces National Contract with Aetna
finance.yahoo.com - June 28 at 7:21 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Says Premera Blue Cross Agrees to Coverage of Thyroid Test
www.streetinsider.com - June 26 at 7:38 PM
finance.yahoo.com logoInterpace Diagnostics Announces Coverage of Thyroid Test By Premera Blue Cross
finance.yahoo.com - June 26 at 7:38 PM
finance.yahoo.com logoInterpace Diagnostics Announces Closing of $13.7 Million Public Offering
finance.yahoo.com - June 21 at 3:31 PM
reuters.com logoBRIEF-Interpace Diagnostics announces pricing
www.reuters.com - June 17 at 6:20 PM
streetinsider.com logoInterpace Diagnostics (IDXG) Prices 12.5M Share Common Offering at $1.10/Sh
www.streetinsider.com - June 17 at 6:20 PM
finance.yahoo.com logoInterpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
finance.yahoo.com - June 16 at 6:42 PM
globenewswire.com logoInterpace Diagnostics Announces Agreement with Einstein Medical Center of Philadelphia
globenewswire.com - June 5 at 10:02 AM
finance.yahoo.com logoInterpace Diagnostics Announces Launch of Enhancement to Thyroid Testing Services
finance.yahoo.com - May 24 at 5:41 PM
finance.yahoo.com logoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 11:37 AM
americanbankingnews.com logoInterpace Diagnostics Group Inc (IDXG) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 4:44 PM
finance.yahoo.com logoEdited Transcript of IDXG earnings conference call or presentation 15-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 11:12 AM
reuters.com logoBRIEF-Interpace Diagnostics qtrly EPS from continuing operations $0.42
www.reuters.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics Group Reports First Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
finance.yahoo.com - May 15 at 10:57 AM
finance.yahoo.com logoInterpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Monday May 15, 2017
finance.yahoo.com - May 12 at 6:31 PM
finance.yahoo.com logoInterpace Diagnostics Presents New Data on PancraGEN® at DDW
finance.yahoo.com - May 10 at 1:25 PM
streetinsider.com logoInterpace Diagnostics (IDXG) to Present New Data in Six Posters Related to PancraGEN at DDW Meeting
www.streetinsider.com - May 1 at 1:22 PM

Social

Chart

Interpace Diagnostics Group (IDXG) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff